CD79A and COVID-19: In contrast, the median levels of plasma IgA and IgG in the COVID-19 patients against the Wuhan strain and all of the SARS-CoV-2 variants increased significantly on day 14 (compared to day 0, all P < 0.001) and declined on day 28 (Fig. 1C and E).